Oral cancer constitutes 1 of the most pernicious cancers with only a 5-year predicted survival following diagnosis. Our research proposes to elucidate some of the underlying causes of oral cancer by focusing on the nature of cell-cell contacts in human oral cancer cells. The long-term goal of our studies is to determine the role of N-glycosylation in the formation of E-cadherin-mediated cell-cell contacts in oral cancer cells. E-cadherin, with its documented role as a tumor suppressor, is the principal cell-cell adhesion receptor in oral epithelial cells. Although changes in N-glycan structures have long been known to be corollaries of tumor formation and metastasis, no information is available about how these structures affect E-cadherin adhesive function. E-cadherin ectodomains, which function in the formation of homotypic cell-cell contacts, have several potential N-glycan addition sites, while the cytosolic tail binds catenins that provide the linkage to the actin cytoskeleton. We have shown that during cell proliferation and migration, E-cadherin is extensively N-glycosylated and present in unstable cell-cell contacts. In contrast, in cytodifferentiated cells, E-cadherin is scarcely N-glycosylated and found in stable junctional complexes associated with the actin cytoskeleton. Our initial studies in vivo and ex vivo show that inappropriate increase in E-cadherin N-glycosylation in differentiated salivary cells reverses E-cadherin-mediated cell-cell contacts from stable to weak. Importantly, many cancer cells have highly N-glycosylated E-cadherin that is present in weak cell-cell contacts. Our hypothesis is that the N-glycosylation status of E- cadherin regulates its tumor suppressive function. We propose to test this hypothesis in 4 specific aims: 1) to demonstrate that highly N-glycosylated E-cadherin is a characteristic of oral cancer cell lines;2) to show that high levels of E-cadherin N-glycosylation drive the formation of unstable E-cadherin-mediated cell-cell contacts;3) to determine the signaling events through which N-glycosylation status of E-cadherin affects oral cancer cell proliferation and survival;and 4) to show that N-glycosylation status of E-cadherin regulates its tumor suppressive activity in SCID mice in vivo. Our proposed studies will increase the understanding of the basis of E-cadherin tumor suppressive activity in oral cancer and will serve as a basis for the development of novel treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE015304-05
Application #
7873024
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Venkatachalam, Sundaresan
Project Start
2006-06-01
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
5
Fiscal Year
2010
Total Cost
$284,265
Indirect Cost
Name
Boston University
Department
Biochemistry
Type
Schools of Dentistry
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Kartha, Vinay K; Alamoud, Khalid A; Sadykov, Khikmet et al. (2018) Functional and genomic analyses reveal therapeutic potential of targeting ?-catenin/CBP activity in head and neck cancer. Genome Med 10:54
Varelas, Xaralabos; Bouchie, Meghan P; Kukuruzinska, Maria A (2014) Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology 24:579-91
Liu, Gangli; Kukuruzinska, Maria A; Xu, Xin (2013) Ror2 may be downregulated in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 116:120
Sengupta, Pritam K; Bouchie, Meghan P; Nita-Lazar, Mihai et al. (2013) Coordinate regulation of N-glycosylation gene DPAGT1, canonical Wnt signaling and E-cadherin adhesion. J Cell Sci 126:484-96
Liu, Gangli; Sengupta, Pritam K; Jamal, Basem et al. (2013) N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem 288:20217-27
Jamal, Basem; Sengupta, Pritam K; Gao, Zhen-Nan et al. (2012) Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer. Oral Oncol 48:523-9
Sengupta, Pritam K; Bouchie, Meghan P; Kukuruzinska, Maria A (2010) N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway. J Biol Chem 285:31164-73
Nita-Lazar, Mihai; Rebustini, Ivan; Walker, Janice et al. (2010) Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res 316:1871-84
Nita-Lazar, Mihai; Noonan, Vikki; Rebustini, Ivan et al. (2009) Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res 69:5673-80
Jamal, Basem T; Nita-Lazar, Mihai; Gao, Zhennan et al. (2009) N-glycosylation status of E-cadherin controls cytoskeletal dynamics through the organization of distinct ?-catenin- and ?-catenin-containing AJs. Cell Health Cytoskelet 2009:67-80